Lemildipine
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Quantitative structure-interaction relationship (QSIR) analyses of 1,4-dihydropyridine drugs were performed on grapefruit juice…
The effects of Lemildipine, a new dihydropyridine calcium channel blocker, on renal hemodynamics and the tubuloglomerular…
The effects of lemildipine, a new dihydropyridine calcium channel blocker, on renal hemodynamics and the tubuloglomerular…
Lemildipine is a 1,4-dihydropyridine calcium channel blocker which is under phase III development by Banyu (Merck and Co), in…
Lemildipine is a 1,4-dihydropyridine calcium channel blocker which is under phase III development by Banyu (Merck and Co), in…
Stereo-selective calcium antagonistic properties of the enantiomers of lemildipine (CAS 94739-29-4, NB-818) were assessed in…